OncoMatch

OncoMatch/Clinical Trials/NCT07702292

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Is NCT07702292 recruiting? Yes, currently enrolling (Sep 2026). This Phase 2 trial studies [68Ga]BED003 for colorectal cancer.

Phase 2RecruitingBlue Earth DiagnosticsNCT07702292Data as of Sep 2026Location: Italy · Netherlands

Treatment: [68Ga]BED003This is a multi-centre, open-label, single-arm, Phase 2 study designed to evaluate the diagnostic performance of \[68Ga\]BED003 in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

[68Ga]BED003

Cancer type

Colorectal Cancer

Ovarian Cancer

Gastric Cancer

Pancreatic Cancer

Breast Carcinoma

Disease stage

Required: Stage IIB, III, IV

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Demographics

Ages ≤ 79

Lab requirements

Kidney function

Significant renal impairment, defined as an estimated glomerular filtration rate below 45 mL/min/1.73m2 or a serum creatinine > 1.5 × the upper limit of normal

Cardiac function

Significant cardiac disorders including recent (in last 3 months) myocardial infarction or clinically significant electrocardiogram (ECG) findings

Significant renal impairment, defined as an estimated glomerular filtration rate below 45 mL/min/1.73m2 or a serum creatinine > 1.5 × the upper limit of normal; Significant cardiac disorders including recent (in last 3 months) myocardial infarction or clinically significant electrocardiogram (ECG) findings

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07702292 currently recruiting?

Yes, this trial is currently recruiting patients.

What disease stage is eligible?

Stage IIB or III or IV is required.

Is there an age limit?

Yes. Patients must be 79 years or younger.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify